IP Library Assignment 051519/0511
Patent Assignment
Reel/Frame 051519/0511

Assignment of Assignor's Interest

Recorded: 2020-01-08 Pages: 21
Assignor
INFINITY PHARMACEUTICALS, INC.
Executed: 2020-01-08
Assignee
ROYALTY SECURITY, LLC
1209 ORANGE STREET, THE CORPORATION TRUST COMPANY, WILMINGTON, DELAWARE, 19801
Covered Properties (56)
Cyclopamine analogs and uses thereof
Application: 60/605,020 →
Cyclopamine analogs and methods of use thereof
Application: 60/617,170 →
Cyclopamine analogues and methods of use thereof
Application: 60/625,676 →
Cyclopamine analogues and methods of use thereof
Application: 60/683,169 →
Cyclopamine analogs and methods of use thereof
Application: 60/878,018 →
Cyclopamine Analogs and Methods of Use Thereof
Application: 60/941,596 →
Cyclopamine Analogs
Application: 16/521,447 →
Publication: US 2020/0121658
Methods of Use for Cyclopamine Analogs
Application: 13/090,694 →
Publication: US 2011/0230509
Methods of Use for Cyclopamine Analogs
Application: 13/475,510 →
Publication: US 2013/0108583
Heterocyclic Cyclopamine Analogs and Methods of Use Thereof
Application: 60/893,595 →
Methods for Stereoselective Reduction
Application: 61/017,162 →
Enzymatic Transamination of Cyclopamine Analogs
Application: 61/231,439 →
Enzymatic Transamination of Cyclopamine Analogs
Application: 14/257,658 →
Publication: US 2014/0371456
Transfer Hydrogenation of Cyclopamine Analogs
Application: 61/382,642 →
Isolation of Cyclopamine
Application: 16/118,338 →
Publication: US 2019/0263852
Methods and Compositions for Identification, Assessment and Treatment of Cancers Associated with Hedgehog Signaling
Application: 61/362,541 →
Methods and Compositions for Identification, Assessment and Treatment of Cancers Associated with Hedgehog Signaling
Application: 61/471,085 →
Methods and Compositions for Identification, Assessment and Treatment of Cancers Associated with Hedgehog Signaling
Application: 61/492,594 →
Methods and Compositions for Identification, Assessment and Treatment of Cancers Associated with Hedgehog Signaling
Application: 13/179,438 →
Publication: US 2012/0010230
Methods and Compositions for Identification, Assessment and Treatment of Cancers Associated with Hedgehog Signaling
Application: 14/455,760 →
Publication: US 2015/0025012
Cyclopamine Analogues and Methods of Use Thereof
Patent: 7,230,004 →
Application: 11/213,534 →
Publication: US 2006/0074030
Cyclopamine Analogues and Methods of Use Thereof
Patent: 7,407,967 →
Application: 11/737,035 →
Publication: US 2007/0191410
Cyclopamine Analogues and Methods of Use Thereof
Patent: 7,875,628 →
Application: 12/171,208 →
Publication: US 2008/0269272
Cyclopamine Analogues and Methods of Use Thereof
Patent: 8,236,956 →
Application: 12/969,024 →
Publication: US 2011/0166353
Cyclopamine Analogs
Patent: 7,812,164 →
Application: 11/965,688 →
Publication: US 2008/0293754
Cyclopamine Analogs
Patent: 8,785,635 →
Application: 12/199,689 →
Publication: US 2009/0012109
Cyclopamine Analogs
Patent: 8,669,365 →
Application: 12/199,722 →
Publication: US 2009/0216022
Cyclopamine Analogs
Patent: 9,492,435 →
Application: 14/203,297 →
Publication: US 2014/0371253
Cyclopamine Analogs
Patent: 9,951,083 →
Application: 15/289,887 →
Publication: US 2017/0022212
Cyclopamine Analogs
Application: 15/936,919 →
Publication: US 2019/0000816
Methods of Use of Cyclopamine Analogs
Patent: 8,017,648 →
Application: 11/965,675 →
Publication: US 2010/0286180
Methods of Use of Cyclopamine Analogs
Patent: 8,227,509 →
Application: 13/191,545 →
Publication: US 2012/0077834
Methods of Use of Cyclopamine Analogs
Patent: 8,895,576 →
Application: 13/475,352 →
Publication: US 2013/0108582
Methods of Use of Cyclopamine Analogs
Patent: 9,145,422 →
Application: 14/054,350 →
Publication: US 2014/0107142
Methods of Use of Cyclopamine Analogs
Patent: 9,669,011 →
Application: 14/841,001 →
Publication: US 2016/0158208
Methods of Use of Cyclopamine Analogs
Application: 15/585,038 →
Publication: US 2017/0360763
Methods of Use of Cyclopamine Analogs
Application: 16/047,008 →
Publication: US 2018/0338962
Cyclopamine Lactam Analogs and Methods of Use Thereof
Patent: 7,964,590 →
Application: 12/044,878 →
Publication: US 2008/0287420
Cyclopamine Lactam Analogs and Methods of Use Thereof
Patent: 8,293,760 →
Application: 13/102,395 →
Publication: US 2012/0015934
Cyclopamine Lactam Analogs and Methods of Use Thereof
Patent: 8,431,566 →
Application: 13/250,080 →
Publication: US 2012/0083484
Heterocyclic Cyclopamine Analogs and Methods of Use Thereof
Patent: 7,648,994 →
Application: 12/044,817 →
Publication: US 2008/0293755
Heterocyclic Cyclopamine Analogs and Methods of Use Thereof
Patent: 7,994,191 →
Application: 12/629,382 →
Publication: US 2010/0144775
Heterocyclic Cyclopamine Analogs and Methods of Use Thereof
Patent: 8,426,436 →
Application: 13/168,590 →
Publication: US 2012/0065218
Methods for Stereoselective Reduction
Patent: 8,716,479 →
Application: 12/810,600 →
Publication: US 2011/0009442
Methods for Stereoselective Reduction
Patent: 9,238,672 →
Application: 14/268,952 →
Publication: US 2014/0357868
Enzymatic Transamination of Cyclopamine Analogs
Patent: 8,703,448 →
Application: 13/175,053 →
Publication: US 2012/0083607
Transfer Hydrogenation of Cyclopamine Analogs
Patent: 9,394,313 →
Application: 13/232,851 →
Publication: US 2012/0065399
Transfer Hydrogenation of Cyclopamine Analogs
Patent: 9,376,447 →
Application: 13/232,898 →
Publication: US 2012/0065400
Transfer Hydrogenation of Cyclopamine Analogs
Patent: 9,879,025 →
Application: 15/191,371 →
Publication: US 2017/0029433
Cyclopamine Analogues and Methods of Use Thereof
Cyclopamine Analogs
Cyclopamine Lactam Analogs and Methods of Use Thereof
Heterocyclic Cyclopamine Analogs and Methods of Use Thereof
Enzymatic Transamination of Cyclopamine Analogs
Transfer Hydrogenation of Cyclopamine Analogs
Isolation of Cyclopamine
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 29, 2005
From: ADAMS, JULIAN; CASTRO, ALFREDO C.; FOLEY, MICHAEL A.; JANARDANAN NAIR, SOMARAJAN NAIR
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 017080/0237 →
Assignment of Assignor's Interest Jun 17, 2008
From: ADAMS, JULIAN; CASTRO, ALFREDO C.; FOLEY, MICHAEL A.; JANARDANAN NAIR, SOMARAJAN NAIR
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 021107/0836 →
Assignment of Assignor's Interest Jul 23, 2008
From: AUSTAD, BRIAN; BEHNKE, MARK L.; CASTRO, ALFREDO C.; CHARETTE, ANDRE B.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 021282/0077 →
Change of Name Aug 5, 2008
From: INFINITY PHARMACEUTICALS, INC.
To: INFINITY DISCOVERY, INC.
Reel/Frame 021339/0289 →
Assignment of Assignor's Interest Aug 29, 2008
From: AUSTAD, BRIAN; BEHNKE, MARK L.; CASTRO, ALFREDO C.; CHARETTE, ANDRE B.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 021464/0382 →
Assignment of Assignor's Interest Sep 26, 2008
From: ADAMS, JULIAN; CASTRO, ALFREDO C.; FOLEY, MICHAEL A.; JANARDANAN NAIR, SOMARAJAN NAIR
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 021593/0594 →
Change of Name Oct 9, 2009
From: INFINITY PHARMACEUTICALS, INC.
To: INFINITY DISCOVERY, INC.
Reel/Frame 023350/0781 →
Assignment of Assignor's Interest Dec 15, 2010
From: MACDOUGALL, JOHN; PAEZ, JUAN GUILLERMO
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 025503/0404 →
Assignment of Assignor's Interest Mar 24, 2011
From: ADAMS, JULIAN; CASTRO, ALFREDO C.; FOLEY, MICHAEL A.; JANARDANANNAIR, SOMARAJANNAIR
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 026011/0720 →
Assignment of Assignor's Interest Apr 13, 2011
From: MCGOVERN, KAREN J.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 026114/0230 →
Assignment of Assignor's Interest May 24, 2011
From: CASTRO, ALFREDO C.; GROGAN, MICHAEL J.; MCGOVERN, KAREN J.; TREMBLAY, MARTIN R.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 026327/0975 →
Assignment of Assignor's Interest May 31, 2011
From: MATSUI, WILLIAM
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 026362/0387 →
Assignment of Assignor's Interest Aug 4, 2011
From: MACDOUGALL, JOHN R.; PAEZ, JUAN GUILLERMO; MCGOVERN, KAREN J.; KUTOK, JEFFERY L.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 026702/0231 →
Assignment of Assignor's Interest Jan 24, 2012
From: WALLERSTEIN, SHELDON L.
To: SAFC, INC.
Reel/Frame 027581/0857 →
Assignment of Assignor's Interest Jan 24, 2012
From: SAFC, INC.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 027582/0330 →
Assignment of Assignor's Interest Jan 24, 2012
From: AUSTAD, BRIAN; BAHADOOR, ADILAH; BELANI, JITENDRA D.; JOHANNES, CHARLES W.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 027582/0538 →
Assignment of Assignor's Interest Feb 3, 2012
From: INFINITY DISCOVERY, INC.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 027648/0451 →
Assignment of Assignor's Interest Feb 3, 2012
From: INFINITY DISCOVERY, INC.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 027648/0661 →
Assignment of Assignor's Interest Feb 3, 2012
From: INFINITY DISCOVERY, INC.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 027648/0699 →
Assignment of Assignor's Interest Mar 11, 2014
From: AUSTAD, BRIAN; BEHNKE, MARK L.; CASTRO, ALFREDO C.; GROGAN, MICHAEL J.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 032402/0472 →
Assignment of Assignor's Interest Apr 22, 2014
From: AUSTAD, BRIAN; BAHADOOR, ADILAH; BELANI, JITENDRA D.; JANARDANANNAIR, SOMARAJANNAIR
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 032726/0043 →
Assignment of Assignor's Interest Apr 22, 2014
From: SAFC, INC.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 032726/0157 →
Assignment of Assignor's Interest Apr 22, 2014
From: WALLERSTEIN, SHELDON L.
To: SAFC, INC.
Reel/Frame 032726/0093 →
Assignment of Assignor's Interest Jun 26, 2014
From: MACDOUGALL, JOHN; MCGOVERN, KAREN J.; PAEZ, JUAN GUILLERMO; KUTOK, JEFFERY L.
To: INFINITY PHARMACEUTICALS, INC.
Reel/Frame 033185/0437 →
Confirmatory License May 21, 2018
From: THE JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 045855/0283 →